| pubmed-article:18502300 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18502300 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18502300 | lifeskim:mentions | umls-concept:C0948089 | lld:lifeskim |
| pubmed-article:18502300 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18502300 | lifeskim:mentions | umls-concept:C1721335 | lld:lifeskim |
| pubmed-article:18502300 | lifeskim:mentions | umls-concept:C1174097 | lld:lifeskim |
| pubmed-article:18502300 | pubmed:issue | 9626 | lld:pubmed |
| pubmed-article:18502300 | pubmed:dateCreated | 2008-5-26 | lld:pubmed |
| pubmed-article:18502300 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:abstractText | Oxidative stress and inflammation are involved in the pathophysiology of atherosclerosis. Our aim was to assess the effects of the antioxidant succinobucol (AGI-1067) on cardiovascular outcomes in patients with recent acute coronary syndromes already managed with conventional treatments. | lld:pubmed |
| pubmed-article:18502300 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18502300 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18502300 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18502300 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18502300 | pubmed:month | May | lld:pubmed |
| pubmed-article:18502300 | pubmed:issn | 1474-547X | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:L'AllierPhili... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:PfefferMarc... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:McMurrayJohn... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:ScottRobertR | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:TardifJean-Cl... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:LewisEldrin... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:KlugEricE | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:SchumiJennife... | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:SmallRobertR | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:ChoiJasmineJ | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:CooperJimJ | lld:pubmed |
| pubmed-article:18502300 | pubmed:author | pubmed-author:Aggressive... | lld:pubmed |
| pubmed-article:18502300 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18502300 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:18502300 | pubmed:volume | 371 | lld:pubmed |
| pubmed-article:18502300 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18502300 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18502300 | pubmed:pagination | 1761-8 | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:meshHeading | pubmed-meshheading:18502300... | lld:pubmed |
| pubmed-article:18502300 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18502300 | pubmed:articleTitle | Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. | lld:pubmed |
| pubmed-article:18502300 | pubmed:affiliation | Montreal Heart Institute, University of Montreal, Montreal, Canada. jean-claude.tardif@icm-mhi.org | lld:pubmed |
| pubmed-article:18502300 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18502300 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18502300 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18502300 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18502300 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18502300 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18502300 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18502300 | lld:pubmed |
